Wexford Laboratories Private Limited

Wexford Laboratories Private Limited - pharma in Tumkur, Karnataka, India. FY 2026 financials & compliance.
CIN U24231KA2002PTC030849 Incorporated 02 August 2002 ROC Bangalore HQ Tumkur, Karnataka, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2024
₹83.63 Cr
▲ 22% YoY
Net profit · FY 2024
₹87.78 Lakh
Net margin 1%
EBITDA · FY 2024
₹4.94 Cr
EBITDA margin 5.9%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹72.15 Lakh
Issued & subscribed
Open charges
₹14.75 Cr
Satisfied ₹8.88 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
164
Provident fund records

About Wexford Laboratories Private Limited

Data last updated:

Wexford Laboratories Private Limited is a private limited company based in Tumkur, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 August 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2002PTC030849. Its GSTIN is 29AAACW4383P4ZG (Karnataka). The company holds 6 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹72.15 Lakh. It is led by directors Bini Deepak and Deepak Badrinarayan.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 18 KIADB Industrial Area Phase I Antharasanahalli, Tumkur, Karnataka, India – 572106.

As per the financials filed for FY 2024, the company reported a revenue of ₹83.63 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹87.78 Lakh (net margin 1%) and EBITDA of ₹4.94 Cr (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.

The company has about 164 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Wexford Laboratories. As per MCA filings, the company has open charges of ₹14.75 Cr and satisfied charges of ₹8.88 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it; 2 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in March 2019. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Inchem Laboratories Private Limited with revenue of ₹84.08 Cr.

Wexford Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-25-0002264). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wexfordindia.com.

Company details

CIN U24231KA2002PTC030849
Registration Number 030849
Incorporation Date 02 August 2002
ROC Bangalore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-25-0002264

Recognitions & Rankings of Wexford Laboratories

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-KR-25-0002264

Contact details

Wexford Laboratories Private Limited's registered office is in Tumkur, Karnataka. Its website is wexfordindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 18 KIADB Industrial Area Phase I Antharasanahalli, Tumkur, Karnataka, India – 572106
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Wexford Laboratories Private Limited, buy the company report.

Comprehensive company report
Wexford Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Wexford Laboratories operates one associated brand: Wexford Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures pharmaceuticals for overseas customers focusing on generics and branded products.wexfordindia.com

Business activity

The main business activity of Wexford Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Wexford Laboratories Private Limited, buy the company report.

Financials of Wexford Laboratories Private Limited

FY 2024 filings available

Wexford Laboratories Private Limited reported revenue of ₹83.63 Cr (up 22% YoY) for FY 2024.

Revenue · FY 2024
₹83.63 Cr ▲ 22%
Net profit · FY 2024
₹87.78 Lakh margin 1%
EBITDA · FY 2024
₹4.94 Cr margin 5.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 14%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▼ 17%
5 years · compounded
▼ 10%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 22% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.94 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹87.78 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.9%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Wexford Laboratories Private Limited, buy the company report.

Board of directors of Wexford Laboratories Private Limited

Wexford Laboratories has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Bini DeepakDirector04 Nov 200224 Years 0 MonthsCurrent
Deepak BadrinarayanDirector02 Aug 200224 Years 3 MonthsCurrent

Peer comparison

Wexford Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Inchem Laboratories Private Limited₹84.08 Cr (FY 2025)12.0%Hyderabad, Telangana, India
Macmillon Pharmaceuticals Private Limited₹83.91 Cr (FY 2024)50.0%Punjab, India
Sunbeam Lifesciences Private Limited₹83.83 Cr (FY 2025)25.0%Puducherry, India
Curetech Formulations Private Limited₹83.74 Cr (FY 2024)4.0%Himachal Pradesh, India
Wexford Laboratories Private Limitedthis company₹83.63 Cr (FY 2024)₹87.78 Lakh1%22.0%164Tumkur, Karnataka, India
J Duncan Healthcare Private Limited₹82.47 Cr (FY 2025)-57.0%Shahapur, Maharashtra, India
Maxheal Pharmaceuticals (India) Limited₹82.41 Cr (FY 2024)10.0%Mumbai, Maharashtra, India
Mepromax Life Sciences Private Limited₹82.29 Cr (FY 2025)2.0%Wadhwan, Gujarat, India

To see the full peer comparison of Wexford Laboratories Private Limited, buy the company report.

Auditor

Wexford Laboratories Private Limited is audited by Narayanan Patil and Ramesh for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Narayanan Patil and RameshFY 2023002395S

Shareholding

The shareholding of Wexford Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Wexford Laboratories Private Limited, buy the company report.

Charges & borrowings

Open charges
₹14.75 Cr
Satisfied charges
₹8.88 Cr
Breakdown by lending institutions
Others₹14.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Sep 2017100148497Others₹14.75 CrOpen
05 Dec 201210392130Corporation Bank₹5.8 LakhSatisfied
26 Oct 201210392126Corporation Bank₹5.75 LakhSatisfied
02 Mar 201210341244Corporation Bank₹8 LakhSatisfied
22 Mar 201010216957Corporation Bank₹7.81 CrSatisfied

To see the full charge records of Wexford Laboratories Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Wexford Laboratories Private Limited has 4 deals on record (4 secondary share transfers); the latest was in March 2019.

Total deals
4
Secondary share transfers
4

Deals on record (4 of 4)

WhenDealAmountParties
Mar 2019Secondary share transferUndisclosedBuyer: 3 individuals
Seller: an individual
Mar 2011Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Mar 2009Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2008Secondary share transferUndisclosedBuyer: an individual
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Wexford Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Wexford Laboratories Private Limited has a workforce of 164 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
164
Active EPFO establishments
2
Employee growth
5.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27164
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Wexford Laboratories Private Limited, buy the company report.

GST

Wexford Laboratories has 6 GST registrations: 2 active and 4 cancelled or inactive.

Total GSTINs
6
Active
2
Cancelled / inactive
4
GSTINStateStatusRegistered on
29AAACW4383P4ZGKarnatakaActive01 Jul 2017
24AAACW4383P1ZTGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Wexford Laboratories Private Limited, buy the company report.

Recent activity

Wexford Laboratories Private Limited has 2 board changes on record since 2002: 2 appointments. The latest: Bini Deepak was appointed as Director on 04 Nov 2002.

AGM
Wexford Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Wexford Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Charges
A charge with Others of Rs. 1,475.44 Lakh registered on 22 Sep 2017 with Charge ID 100148497 was modified on 28 Jan 2023.
Charges
A charge registered on 05 Dec 2012 via Charge ID 10392130 with Corporation Bank was fully satisfied on 05 Jan 2018.
Charges
A charge registered on 26 Oct 2012 via Charge ID 10392126 with Corporation Bank was fully satisfied on 05 Jan 2018.
Charges
A charge registered on 02 Mar 2012 via Charge ID 10341244 with Corporation Bank was fully satisfied on 05 Jan 2018.
Charges
A charge registered on 22 Mar 2010 via Charge ID 10216957 with Corporation Bank was fully satisfied on 05 Jan 2018.
Charges
A charge registered on 25 Jan 2005 via Charge ID 90192943 with Corporation Bank was fully satisfied on 05 Jan 2018.
Charges
A charge with Others amounted to Rs. 1,475.44 Lakh with Charge ID 100148497 was registered on 22 Sep 2017.
Charges
A charge with Corporation Bank amounted to Rs. 5.80 Lakh with Charge ID 10392130 was registered on 05 Dec 2012.
Charges
A charge with Corporation Bank amounted to Rs. 5.75 Lakh with Charge ID 10392126 was registered on 26 Oct 2012.
Charges
A charge with Corporation Bank of Rs. 780.68 Lakh registered on 22 Mar 2010 with Charge ID 10216957 was modified on 10 Aug 2012.

7 earlier events are in the company report.

Frequently asked questions

Wexford Laboratories is an active private limited company based in Tumkur, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 August 2002 (24+ years old) and is registered under CIN U24231KA2002PTC030849.

Wexford Laboratories has 2 current directors:

The latest financial statements of Wexford Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Wexford Laboratories is 29AAACW4383P4ZG, registered in Karnataka. The company has 6 GST registrations in all, of which 2 are active and 4 are cancelled or inactive. Other active GSTINs include 24AAACW4383P1ZT (Gujarat).

The CIN (Corporate Identification Number) of Wexford Laboratories is U24231KA2002PTC030849. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Wexford Laboratories has 7 court cases on record: 2 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.

Wexford Laboratories was incorporated on 02 August 2002, making it 24+ years old. It is registered with the Registrar of Companies, Bangalore.

Wexford Laboratories has 4 deals on record (4 secondary share transfers); the latest was in March 2019.

The peers of Wexford Laboratories by revenue are Inchem Laboratories Private Limited, Macmillon Pharmaceuticals Private Limited, Sunbeam Lifesciences Private Limited, Curetech Formulations Private Limited, J Duncan Healthcare Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Bini Deepak was appointed as Director on 04 Nov 2002. Deepak Badrinarayan was appointed as Director on 02 Aug 2002.

Yes, Wexford Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-25-0002264).